Oncolytic Virus Therapy Market to grow at a CAGR of 19.32% in the forecast period 2019-26 as the world is introduced to a safer way to fight cancer

Hyderabad, April 12, 2019 -- The "Oncolytic Virus Therapy Market : Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2026" report has been added to Datamintelligence.com's offering.
An oncolytic virus is a genetically engineered or naturally occurring virus that can imitate in selected terms and kill cancer cells without harming the normal tissues. Oncolytic Virus therapy is a new therapeutic approach for treating cancer and has shown promising results globally.
Oncolytic Virus Therapy Market Trends : Drivers and Restraints
⦁The rising prevalence of cancer cases and increasing development of cancer-treating therapies such as an oncolytic virus is driving the market growth globally.
⦁Technological developments such as natural killer cells and use of combination therapies are also driving the market growth. Further ongoing development of virus therapies globally, which are in the pipeline will further enhance the growth of oncolytic virus therapy market in the forecast period.
⦁The immune reaction to the virus based therapies by repeated administration of therapeutics for treating cancer is a critical restraint that hampering market growth.
⦁The high cost of oncolytic virus therapy is further affecting market growth, especially in developing countries.
Oncolytic Virus Therapy Market Segmentation:
⦁Global Oncolytic Virus Therapy Market is segmented by application type, by drug class, and therapy type.
⦁By application, the market is segmented into Prostate cancer, Melanoma, Ovarian Cancer, Breast Cancer, and others. Melanoma is accounted for the largest share as most of the cancer therapies are developed for Melanoma cancers. They are increasing prostate cancer cases also leading to a steady growth rate in prostate cancer therapies in recent years.
⦁By Drug class the market is segmented into Onyx-15, Talimogene laherparepvec, Reolysin, RIGVIR. Talimogene laherparepvec is the most significant drug class that accounted for a significant share in the market and is mainly due to its large penetration in cancer treatment.
Oncolytic Virus Therapy Market Geographical Share
⦁By Geography the market is segmented into North America, South America, Europe, Asia Pacific and rest of the World. North America is the leading market globally and is mainly due to increased cancer cases associated with hectic lifestyles. Well-developed healthcare infrastructure is further supported by the growth in the region.
Companies Covered
Oncolytic Virus Therapy is highly concentrated among a few key players such as Amgen, Shanghai Sunway Biotech Co. Ltd, and RIGVIR. Companies in the industry operate on low-profit margins, which is likely to worsen further during the forecast period. Industry players are focusing on implementing inorganic growth strategies to expand their presence in the market.

Key Points covered in the report
⦁Oncolytic Virus Therapy Market – Methodology and Scope
⦁Oncolytic Virus Therapy Market - Trends
⦁Oncolytic Virus Therapy Market – Industry Analysis
⦁Geographical Analysis
⦁Competitive Landscape
⦁Company Profiles

Oncolytic Virus Therapy Market Key Companies

For more information about this report visit https://www.datamintelligence.com/research-report/oncolytic-virus-therapy-market
DataM Intelligence also offers Custom Research services providing focused, comprehensive and tailored research.

DataM Intelligence 4Market Research is a market intelligence platform which gives access to syndicated, customised reports to its clients at one place. As a firm with rich experience in research and consulting across multiple domains we are one stop solution that will cater to the needs of clients in key business areas.

1st floor, Phoenix Tech Tower, Plo no: 14/46, Habsidguda, IDA-Uppal, Hyderabad-500039, Telangana.

This release was published on openPR.